Asset Details
Do you wish to reserve the book?
Retrogasserian Glycerol Rhizotomy (RGGR) for Trigeminal Neuralgia Induced by Postvaccination Herpetic Reactivation: A Rare Case Report
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Retrogasserian Glycerol Rhizotomy (RGGR) for Trigeminal Neuralgia Induced by Postvaccination Herpetic Reactivation: A Rare Case Report
Do you wish to request the book?
Retrogasserian Glycerol Rhizotomy (RGGR) for Trigeminal Neuralgia Induced by Postvaccination Herpetic Reactivation: A Rare Case Report
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Retrogasserian Glycerol Rhizotomy (RGGR) for Trigeminal Neuralgia Induced by Postvaccination Herpetic Reactivation: A Rare Case Report
2025
Overview
Reports on surgical treatment for postherpetic trigeminal neuralgia after COVID vaccination have not been found in the literature. Here, we described a case of postherpetic trigeminal neuralgia after COVID vaccination that was treated with percutaneous retrogasserian glycerol rhizotomy (PRGR) resulting in complete pain relief. We reported a case involving a 70‐year‐old female who had herpes zoster infection in the ophthalmic branch (V1) dermatome following COVID vaccination and presented with paroxysmal electric shock‐like sensation without a trigger. Her pain was refractory to medical management. Her Barrow Neurological Institute pain intensity score was IV. Magnetic resonance imaging of the brain was normal. PRGR was performed. The patient's pain decreased over the next 2 h, and she was pain‐free from post‐procedure Day 2 while taking carbamazepine 400 mg/day, which was tapered over 2 weeks. At her 3‐month follow‐up, the patient was reviewed and remained pain‐free. Percutaneous treatment of postherpetic trigeminal neuralgia may be considered the treatment of choice in vaccination‐induced postherpetic trigeminal neuralgia.
Publisher
John Wiley & Sons, Inc,John Wiley and Sons Inc,Wiley
Subject
